DL-5-Hydroxylysine hydrochloride Size:Contact [email protected] for quotation Smiles: C[C@@H]1CN[C@@]2(CC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@H](CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C)O[C@@H]1O[C@H](CO)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O[C@@H]3OC[C@@H](O)[C@H](O)[C@H]3O)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O

Smiles: C[C@@H]1CN[C@@]2(CC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@H](CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C)O[C@@H]1O[C@H](CO)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O[C@@H]3OC[C@@H](O)[C@H](O)[C@H]3O)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O

Chemical Name: 2-{4-[({[2

1 hour) pretreatment blocks VE-P labeling of ATP6V1G1 but not ATP1V1B2 or ATP6V1D in a competitive binding assay

Olafertinib has the potential for NSCLC research

GSK-7975A completely inhibits calcium influx through CRAC channels

DL-5-Hydroxylysine hydrochloride Size:Contact [email protected] for quotation Smiles: C[C@@H]1CN[C@@]2(CC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@H](CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C)O[C@@H]1O[C@H](CO)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O[C@@H]3OC[C@@H](O)[C@H](O)[C@H]3O)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1ODL 5 Hydroxylysine hydrochloride is an endogenous metabolite. Product information CAS Number: 13204 98 3 Molecular Weight: 198. 65 Formula: C6H15ClN2O3 Chemical Name: 2,6 diamino 5 hydroxyhexanoic acid hydrochloride Smiles: Cl. NC(CCC(O)CN)C(O)=O InChiKey: MJXVOTKVFFAZQJ UHFFFAOYSA N InChi: InChI=1S C6H14N2O3. ClH c7 3 4(9)1 2 5(8)6(10)11; h4 5,9H,1 3,7 8H2,(H,10,11); 1H Technical Data Appearance: Solid Power Purity: 98% (or refer to the Certificate